Annual FCF
-$214.59 M
-$26.20 M-13.91%
31 March 2024
Summary:
Immunovant annual free cash flow is currently -$214.59 million, with the most recent change of -$26.20 million (-13.91%) on 31 March 2024. During the last 3 years, it has fallen by -$131.05 million (-156.88%). IMVT annual FCF is now -301.94% below its all-time high of -$53.39 million, reached on 31 March 2020.IMVT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$88.84 M
-$12.46 M-16.32%
30 September 2024
Summary:
Immunovant quarterly free cash flow is currently -$88.84 million, with the most recent change of -$12.46 million (-16.32%) on 30 September 2024. Over the past year, it has dropped by -$28.75 million (-47.84%). IMVT quarterly FCF is now -22210650.00% below its all-time high of -$400.00, reached on 31 March 2019.IMVT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$272.30 M
-$28.75 M-11.80%
30 September 2024
Summary:
Immunovant TTM free cash flow is currently -$272.30 million, with the most recent change of -$28.75 million (-11.80%) on 30 September 2024. Over the past year, it has dropped by -$62.48 million (-29.78%). IMVT TTM FCF is now -68075400.00% below its all-time high of -$400.00, reached on 31 March 2019.IMVT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.9% | -47.8% | -29.8% |
| 3 y3 years | -156.9% | -342.2% | -213.9% |
| 5 y5 years | - | -10000.0% | -10000.0% |
IMVT Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -156.9% | at low | -342.2% | at low | -213.9% | at low |
| 5 y | 5 years | -301.9% | at low | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | -301.9% | at low | <-9999.0% | at low | <-9999.0% | at low |
Immunovant Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$88.84 M(+16.3%) | -$272.30 M(+11.8%) |
| June 2024 | - | -$76.38 M(+27.6%) | -$243.55 M(+13.5%) |
| Mar 2024 | -$214.59 M(+13.9%) | -$59.85 M(+26.7%) | -$214.59 M(+1.9%) |
| Dec 2023 | - | -$47.23 M(-21.4%) | -$210.56 M(+0.4%) |
| Sept 2023 | - | -$60.09 M(+26.7%) | -$209.82 M(+23.5%) |
| June 2023 | - | -$47.41 M(-15.1%) | -$169.94 M(-9.8%) |
| Mar 2023 | -$188.39 M(+77.1%) | -$55.82 M(+20.1%) | -$188.39 M(+13.7%) |
| Dec 2022 | - | -$46.49 M(+130.0%) | -$165.65 M(+9.6%) |
| Sept 2022 | - | -$20.22 M(-69.3%) | -$151.12 M(+0.1%) |
| June 2022 | - | -$65.86 M(+99.1%) | -$151.00 M(+42.0%) |
| Mar 2022 | -$106.37 M | -$33.07 M(+3.5%) | -$106.37 M(+10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$31.97 M(+59.1%) | -$95.88 M(+10.5%) |
| Sept 2021 | - | -$20.09 M(-5.4%) | -$86.76 M(-4.6%) |
| June 2021 | - | -$21.23 M(-6.0%) | -$90.92 M(+8.8%) |
| Mar 2021 | -$83.54 M(+56.5%) | -$22.59 M(-1.1%) | -$83.54 M(+37.1%) |
| Dec 2020 | - | -$22.84 M(-5.8%) | -$60.95 M(+60.0%) |
| Sept 2020 | - | -$24.26 M(+75.2%) | -$38.10 M(+169.3%) |
| June 2020 | - | -$13.85 M(+4492.0%) | -$14.15 M(+2558.1%) |
| Mar 2020 | -$53.39 M | - | - |
| Sept 2019 | - | -$301.50 K(+30.9%) | -$532.20 K(+130.7%) |
| June 2019 | - | -$230.30 K(>+9900.0%) | -$230.70 K(>+9900.0%) |
| Mar 2019 | - | -$400.00 | -$400.00 |
FAQ
- What is Immunovant annual free cash flow?
- What is the all time high annual FCF for Immunovant?
- What is Immunovant annual FCF year-on-year change?
- What is Immunovant quarterly free cash flow?
- What is the all time high quarterly FCF for Immunovant?
- What is Immunovant quarterly FCF year-on-year change?
- What is Immunovant TTM free cash flow?
- What is the all time high TTM FCF for Immunovant?
- What is Immunovant TTM FCF year-on-year change?
What is Immunovant annual free cash flow?
The current annual FCF of IMVT is -$214.59 M
What is the all time high annual FCF for Immunovant?
Immunovant all-time high annual free cash flow is -$53.39 M
What is Immunovant annual FCF year-on-year change?
Over the past year, IMVT annual free cash flow has changed by -$26.20 M (-13.91%)
What is Immunovant quarterly free cash flow?
The current quarterly FCF of IMVT is -$88.84 M
What is the all time high quarterly FCF for Immunovant?
Immunovant all-time high quarterly free cash flow is -$400.00
What is Immunovant quarterly FCF year-on-year change?
Over the past year, IMVT quarterly free cash flow has changed by -$28.75 M (-47.84%)
What is Immunovant TTM free cash flow?
The current TTM FCF of IMVT is -$272.30 M
What is the all time high TTM FCF for Immunovant?
Immunovant all-time high TTM free cash flow is -$400.00
What is Immunovant TTM FCF year-on-year change?
Over the past year, IMVT TTM free cash flow has changed by -$62.48 M (-29.78%)